World Health Organization. Suicide in the world: global health estimates: World Health Organization; 2019. Available from: https://apps.who.int/iris/handle/10665/326948. Accessed 20 Mar 2021
World Health Organization. Preventing suicide: a global imperative: World Health Organization; 2014. Available from: https://www.who.int/mental_health/suicide-prevention/world_report_2014/en/. Accessed 18 May 2021
Orsolini L, Latini R, Pompili M, Serafini G, Volpe U, Vellante F, et al. Understanding the complex of suicide in depression: from research to clinics. Psychiatry Investig. 2020;17(3):207–21.
Article
PubMed
PubMed Central
Google Scholar
Ribeiro JD, Huang X, Fox KR, Franklin JC. Depression and hopelessness as risk factors for suicide ideation, attempts and death: meta-analysis of longitudinal studies. Br J Psychiatry. 2018;212(5):279–86.
Article
PubMed
Google Scholar
Osby U, Brandt L, Correia N, Ekbom A, Sparén P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry. 2001;58:844–50.
Article
PubMed
CAS
Google Scholar
Sokero TP, Melartin TK, Rytsälä HJ, Leskelä US, Lestelä-Mielonen PS, Isometsä ET. Suicidal ideation and attempts among psychiatric patients with major depressive disorder. J Clin Psychiatry. 2003;64:1094–100.
Article
PubMed
Google Scholar
Dong M, Zeng LN, Lu L, Li XH, Ungvari GS, Ng CH, et al. Prevalence of suicide attempt in individuals with major depressive disorder: a meta-analysis of observational surveys. Psychol Med. 2019;49(10):1691–704.
Article
PubMed
Google Scholar
Park S, Lee MS, Hahn SW, Si TM, Kanba S, Chong MY, et al. Suicidal thoughts/acts and clinical correlates in patients with depressive disorders in Asians: results from the REAP-AD study. Acta Neuropsychiatr. 2016;28(6):337–45.
Article
PubMed
Google Scholar
Maramis MM, Pantouw JG, Lesmana CBJ. Depression screening in Surabaya Indonesia: Urgent need for better mental health care for high-risk communities and suicide prevention for men. Int J Soc Psychiatry. 2021;67(5):421–31.
Chan LF, Maniam T, Shamsul AS. Suicide attempts among depressed inpatients with depressive disorder in a Malaysian sample. Psychosocial and clinical risk factors. Crisis. 2011;32(5):283–7.
Article
PubMed
CAS
Google Scholar
Khan TM, Sulaiman SA, Hassali MA. Factors associated with suicidal behavior among depressed patients in Penang, Malaysia. Arch Med Sci. 2012;8(4):697–703.
Article
PubMed
PubMed Central
Google Scholar
Lim A, Lee AR, Hatim A, Tian-Mei S, Liu CY, Jeon HJ, et al. Clinical and sociodemographic correlates of suicidality in patients with major depressive disorder from six Asian countries. BMC Psychiatry. 2014;14:37.
Article
PubMed
PubMed Central
Google Scholar
Subramaniam M, Abdin E, Seow EL, Picco L, Vaingankar JA, Chong SA. Suicidal ideation, suicidal plan and suicidal attempts among those with major depressive disorder. Ann Acad Med Singap. 2014;43(8):412–21.
Article
PubMed
Google Scholar
Chen YY, Wu KC, Yousuf S, Yip PS. Suicide in Asia: opportunities and challenges. Epidemiol Rev. 2012;34:129–44.
Article
PubMed
CAS
Google Scholar
Chu C, Van Orden KA, Ribeiro JD, Joiner TE. Does the timing of suicide risk assessments influence ratings of risk severity? Prof Psychol Res Pr. 2017;48(2):107–14.
Article
PubMed
PubMed Central
Google Scholar
Richards JE, Whiteside U, Ludman EJ, Pabiniak C, Kirlin B, Hidalgo R, et al. Understanding why patients may not report suicidal ideation at a health care visit prior to a suicide attempt: a qualitative study. Psychiatr Serv. 2019;70(1):40–5.
Article
PubMed
Google Scholar
Turecki G, Brent DA, Gunnell D, O'Connor RC, Oquendo MA, Pirkis J, et al. Suicide and suicide risk. Nat Rev Dis Primers. 2019;5(1):74.
Article
PubMed
Google Scholar
American Psychiatric Association. Clinical practice guideline for the treatment of patients with major depressive disorder. 2010. Available from: https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf. Accessed 17 Nov 2020.
Google Scholar
Lam RW, McIntosh D, Wang J, Enns MW, Kolivakis T, Michalak EE. Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 1. Disease burden and principles of care. Can J Psychiatr. 2016;61(9):510–23.
Article
Google Scholar
National Institute for Health & Clinical Excellence. The NICE guideline on the treatment and management of depression in adults. 2020. Available from: https://www.nice.org.uk/guidance/cg90/evidence/full-guidline-pdf-4840934509. Accessed 18 Nov 2020.
Google Scholar
Singapore Ministry of Health. 2012. Depression Clinical Practice Guidelines. Available from: https://www.moh.gov.sg/docs/librariesprovider4/guidelines/depression-cpg_r14_final.pdf. Accessed 17 Nov 2020.
Google Scholar
Malaysia Ministry of Health, Malaysian Psychiatric Association, Academy of Medicine Malaysia. Clinical Practice Guidelines for the management of major depressive disorder. 2nd ed; 2019. Available from: https://umexpert.um.edu.my/public_view.php?type=publication&row=OTA1ODA%3D. Accessed 17 Nov 2020
Google Scholar
Lolito M, Cook E. A review of suicide risk assessment instruments and approaches. Ment Health Clin. 2015;5(5):216–23.
Article
Google Scholar
Gabriel FC, de Melo DO, Fráguas R, Leite-Santos NC, Mantovani da Silva RA, Ribeiro E. Pharmacological treatment of depression: a systematic review comparing clinical practice guideline recommendations. PLoS One. 2020;15(4):e0231700.
Article
PubMed
PubMed Central
CAS
Google Scholar
Nair R, Aggarwal R, Khanna D. Methods of formal consensus in classification/diagnostic criteria and guideline development. Semin Arthritis Rheum. 2011;41(2):95–105.
Article
PubMed
PubMed Central
Google Scholar
Bennabi D, Charpeaud T, Yrondi A, Genty JB, Destouches S, Lancrenon S, et al. Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and Neuropsychopharmacology and the foundation FondaMental. BMC Psychiatry. 2019;19(1):262.
Article
PubMed
PubMed Central
CAS
Google Scholar
Silverman MM. Suicide risk assessment and suicide risk formulation: essential components of the therapeutic risk management model. J Psychiatr Pract. 2014;20(5):373–8.
Article
PubMed
Google Scholar
Ng CWM, How CH, Ng YP. Depression in primary care: assessing suicide risk. Singap Med J. 2017;58(2):72–7.
Article
Google Scholar
Runeson B, Odeberg J, Pettersson A, Edbom T, Jildevik Adamsson I, Waern M. Instruments for the assessment of suicide risk: a systematic review evaluating the certainty of the evidence. PLoS One. 2017;12(7):e0180292.
Article
PubMed
PubMed Central
CAS
Google Scholar
Wortzel HS, Homaifar B, Matarazzo B, Brenner LA. Therapeutic risk management of the suicidal patient: stratifying risk in terms of severity and temporality. J Psychiatr Pract. 2014;20(1):63–7.
Article
PubMed
Google Scholar
Pisani AR, Murrie DC, Silverman MM. Reformulating suicide risk formulation: from prediction to prevention. Acad Psychiatry. 2016;40(4):623–9.
Article
PubMed
Google Scholar
Wasserman D, Rihmer Z, Rujescu D, Sarchiapone M, Sokolowski M, Titelman D, et al. The European Psychiatric Association (EPA) guidance on suicide treatment and prevention. Eur Psychiatry. 2012;27(2):124–41.
Article
Google Scholar
Milev RV, Giacobbe P, Kennedy SH, Blumberger DM, Daskalakis ZJ, Downar J, et al. Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 4. Neurostimulation treatments. Can J Psychiatr. 2016;61(9):561–75.
Article
Google Scholar
Malhi GS, Bell E, Bassett D, Boyce P, Bryant R, Hazell P, et al. The 2020 Royal Australian and new Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry. 2021 Jan;55(1):7–117.
Article
PubMed
Google Scholar
Cleare A, Pariante CM, Young AH, Anderson IM, Christmas D, Cowen PJ, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol. 2015;29(5):459–525.
Article
PubMed
CAS
Google Scholar
Fornaro M, Anastasia A, Valchera A, Carano A, Orsolini L, Vellante F, et al. The FDA “black box” warning on antidepressant suicide risk in young adults: more harm than benefits? Front Psychiatry. 2019;10:294.
Article
PubMed
PubMed Central
Google Scholar
Dold M, Kasper S. Evidence-based pharmacotherapy of treatment-resistant unipolar depression. Int J Psychiatry Clin Pract. 2017;21(1):13–23.
Article
PubMed
CAS
Google Scholar
Bushnell GA, Stürmer T, Gaynes BN, Pate V, Miller M. Simultaneous antidepressant and benzodiazepine new use and subsequent long-term benzodiazepine use in adults with depression, United States, 2001–2014. JAMA Psychiatry. 2017;74(7):747–55.
Article
PubMed
PubMed Central
Google Scholar
Ogawa Y, Takeshima N, Hayasaka Y, Tajika A, Watanabe N, Streiner D, et al. Antidepressants plus benzodiazepines for adults with major depression. Cochrane Database Syst Rev. 2019;6(6):CD001026.
PubMed
Google Scholar
Wright BM, Eiland EH 3rd, Lorenz R. Augmentation with atypical antipsychotics for depression: a review of evidence-base support from the medical literature. Pharmacotherapy. 2013;33(3):344–59.
Article
PubMed
CAS
Google Scholar
D’Anci KE, Uhl S, Giradi G, Martin C. Treatments for the prevention and management of suicide: a systematic review. Ann Intern Med. 2019;171(5):334–42.
Article
PubMed
Google Scholar
Calati R, Courtet P. Is psychotherapy effective for reducing suicide attempt and non-suicidal self-injury rates? Meta-analysis and meta-regression of literature data. J Psychiatr Res. 2016;79:8–20.
Article
PubMed
Google Scholar
Hawton K, Witt KG, Salisbury TLT, Arensman E, Gunnell D, Hazell P, et al. Psychosocial interventions following self-harm in adults: a systematic review and meta-analysis. Lancet Psychiatry. 2016;3(8):740–50.
Article
PubMed
Google Scholar
Méndez-Bustos P, Calati R, Rubio-Ramírez F, Olié E, Courtet P, Lopez-Castroman J. Effectiveness of psychotherapy on suicidal risk: a systematic review of observation studies. Front Psychol. 2019;10:277.
Article
PubMed
PubMed Central
Google Scholar
Dunlop BW. Evidence-based applications of combination psychotherapy and pharmacotherapy for depression. Focus (Am Psychiatr Publ). 2016;14(2):156–73.
Google Scholar
Machado-Vieira R, Baumann J, Wheeler-Castillo C, Latov D, Henter ID, Salvadore G, et al. The timing of antidepressant effects: a comparison of diverse pharmacological and somatic treatments. Pharmaceuticals (Basel). 2010;3(1):19–41.
Article
CAS
Google Scholar
Nelson JC, Baumann P, Delucchi K, Joffe R, Katona C. A systematic review and meta-analysis of lithium augmentation of tricyclic and second -generation antidepressants in major depression. J Affect Disord. 2014;168:269–75.
Article
PubMed
CAS
Google Scholar
Guzetta F, Tondo L, Centorrino F, Baldessarini RJ. Lithium treatment reduces suicide risk in recurrent major depressive disorder. J Clin Psychiatry. 2007;68(3):380–3.
Article
Google Scholar
Cipriani A, Hawton K, Stockton S, Geddes JR. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ. 2013;346:f3646.
Article
PubMed
Google Scholar
Tondo L, Baldessarini RJ. Suicidal behavior in mood disorders: response to pharmacological treatment. Curr Psychiatry Rep. 2016;18(9):88.
Article
PubMed
Google Scholar
Malhi GS, Morris G, Bell E, Hamilton A. A new paradigm for achieving a rapid antidepressant response. Drugs. 2020;80(8):75564.
Davis LL, Ryan W, Adinoff B, Petty F. Comprehensive review of the psychiatric uses of valproate. J Clin Psychopharmacol. 2000;20(suppl 1):S1–17.
Article
Google Scholar
Klonsky ED, May A. Rethinking impulsivity in suicide. Suicide Life Threat Behav. 2010;40(6):612–9.
Article
PubMed
Google Scholar
Domany Y, Shelton RC, McCullumsmith CB. Ketamine for acute suicidal ideation. An emergency department intervention: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Depress Anxiety. 2020;37(3):224–33.
Article
PubMed
CAS
Google Scholar
Dadiomov D, Lee K. The effects of ketamine on suicidality across various formulations and study settings. Ment Health Clin. 2019;9(1):48–60.
Article
PubMed
PubMed Central
Google Scholar
Lascelles K, Marzano L, Brand F, Trueman H, McShane R, Hawton K. Effects of ketamine treatment on suicidal ideation: a qualitative study of patients’ accounts following treatment for depression in a UK ketamine clinic. BMJ Open. 2019;9(8):e029108.
Article
PubMed
PubMed Central
Google Scholar
Chan LF, Eu CL, Soh SY, Maniam T, Kadir ZS, Chong BT, Loo JL, Sharip S, Wong VC, Loo TH, Ng YP. Is ketamine the future clozapine for depression? A case series and literature review on maintenance ketamine in treatment-resistant depression with suicidal behavior. J Psychiatr Pract. 2018;24(4):279–291.
United States Food and Drug Administration. Spravato prescribing information. 2020. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211243s004lbl.pdf. Accessed on 12 April 2021.
Google Scholar
European Medicines Agency. Spravato. 2021. Available from: https://www.ema.europa.eu/en/documents/product-information/spravato-epar-product-information_en.pdf. Accessed on 12 April 2021.
Google Scholar
Malaysia National Pharmaceutical Regulatory Agency. New products approved DCA354. 2021. Available from: https://www.npra.gov.my/index.php/en/informationen/new-products-indication/new-products-approved-quest3.html. Accessed 12 April 2021.
Google Scholar
Singapore Health Sciences Authority. New drug approvals – Oct 2020. Available from: https://www.hsa.gov.sg/announcements/new-drug-approval/new-drug-approvals%2D%2D-oct-2020. Accessed 12 April 2021.
Indonesia Badan Pengawas Obat dan Makanan RI. 2021. Available from: https://cekbpom.pom.go.id/index.php/home/produk/9uovm68qit922rsgvv6k2s3m23/all/row/10/page/1/order/4/DESC/search/5/esketamine.
Fu DJ, Ionescu DF, Li X, Lane R, Lim P, Sanacora G, et al. Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients who have active suicidal ideation with intent: double-blind, randomized study (ASPIRE I). J Clin Psychiatry. 2020;81(3):19m13191.
Article
PubMed
Google Scholar
Ionescu DF, Fu DJ, Qiu X, Lane R, Lim P, Kasper S, et al. Esketamine nasal spray for rapid reduction of major depressive symptoms in patients with major depressive disorder who have active suicide ideation with intent: results of a phase 3, double-blind, randomized study (ASPIRE II). Int J Neuropsychopharmacol. 2021;24(1):22–31.
Article
PubMed
Google Scholar
Jelovac A, Kolshus E, McLoughlin DM. Relapse following successful electroconvulsive therapy for major depression: a meta-analysis. Neuropsychopharmacology. 2013;38(12):2467–74.
Article
PubMed
PubMed Central
CAS
Google Scholar
Abdelnaim MA, Langguth B, Deppe M, Mohonko A, Kreuzer PM, Poeppl TB, et al. Anti-suicidal efficacy of repetitive transcranial magnetic stimulation in depressive patients: a retrospective analysis of a large sample. Front Psychiatry. 2020;10:929.
Article
PubMed
PubMed Central
Google Scholar
Dai L, Wang P, Zhang P, Guo Q, Du H, Li F, et al. The therapeutic effect of repetitive transcranial magnetic stimulation in elderly depression patients. Medicine (Baltimore). 2020;99(32):e21493.
Article
CAS
Google Scholar
Erlangsen A, Lind BD, Stuart EA, Qin P, Stenager E, Larsen KJ, et al. Short-terms and long-term effects of psychosocial therapy for people after deliverate self-harm: a register-based, nationwide multicentre study using propensity score matching. Lancet. 2015;2:49–58.
Google Scholar
Jobes DA, Wong SA, Conrad AK, Drozd JF, Neal-Walden T. The collaborative assessment and management of suicidality versus treatment as usual: a retrospective study with suicidal outpatients. Suicide Life Threat Behav. 2005;35(5):483–97.
Article
PubMed
Google Scholar
Ellis TE, Rufino KA, Allen JG. A controlled comparison trial of the collaborative assessment and Management of Suicidality (CAMS) in an inpatient setting: outcomes at discharge and six-month follow-up. Psychiatry Res. 2017;249:252–60.
Article
PubMed
Google Scholar
Hanratty D, Kilicaslan J, Wilding H, Castle D. A systematic review of efficacy of collaborative assessment and Management of Suicidality (CAMS) in managing suicide risk and deliberate self-harm in adult populations. Australas Psychiatry. 2019;27(6):559–64.
Article
PubMed
Google Scholar
Tighe J, Nicholas J, Shand F, Christensen H. Efficacy of acceptance and commitment therapy in reducing suicidal ideation and deliberate self-harm: systematic review. JMIR Ment Health. 2018;5(2):e10732.
Article
PubMed
PubMed Central
Google Scholar
Vogt KS, Norman P. Is mentalization-based therapy effective in treating the symptoms of borderline personality disorder? A systematic review. Psychol Psychother. 2019;92(4):441–64.
Article
PubMed
Google Scholar
Philips B, Wennberg P, Konradsson P, Franck J. Mentalization-based treatment for concurrent borderline personality disorder and substance use disorder: a randomized controlled feasibility study. Eur Addict Res. 2018;24(1):1–8.
Article
PubMed
Google Scholar
Riblet NBV, Shiner B, Young-Xu Y, Watts BV. Strategies to prevent death by suicide: meta-analysis of randomized controlled trials. Br J Psychiatry. 2017;210(6):396–402.
Article
PubMed
Google Scholar
Stanley B, Brown GK, Brenner LA, Galfalvy HC, Currier GW, Knox KL, et al. Comparison of the safety planning intervention with follow-up vs usual care of suicidal patients treated in the emergency department. JAMA Psychiatry. 2018;75:894–900.
Article
PubMed
PubMed Central
Google Scholar
Bryan CJ, Mintz J, Clemans TA, Leeson B, Burch TS, Williams SR, et al. Effect of crisis response planning versus contracts for safety on suicide risk in US Army soldiers: a randomized clinical trial. J Affect Disord. 2017;212:64–72.
Article
PubMed
Google Scholar
O’Connor RC, Ferguson E, Scott F, Smyth R, McDaid D, Park AL, et al. A brief psychological intervention to reduce repetition of self-harm in patients admitted to hospital following a suicide attempt: a randomized controlled trial. Lancet Psychiatry. 2017;4:451–60.
Article
PubMed
PubMed Central
Google Scholar
Gysin-Maillart A, Schwab S, Soravia L, Megert M, Michel K. A novel brief therapy for patients who attempt suicide: a 24-months follow-up randomized controlled study of the attempted suicide short intervention program (ASSIP). PLoS Med. 2016;13:e1001968.
Article
PubMed
PubMed Central
Google Scholar
Stanley B, Brown GK. Safety planning intervention: a brief intervention to mitigate suicide risk. Cognit Behv Pract. 2012;19:256–64.
Article
Google Scholar
Edwards SJ, Sachmann MD. No-suicide contracts, no-suicide agreements, and no-suicide assurances: a study of their nature, utilization, perceived effectiveness and potential to cause harm. Crisis. 2010;31(6):290–302.
Article
PubMed
Google Scholar
Alphs L, Fu DJ, Williamson D, Turkoz I, Jamieson C, Revicki D, et al. Suicide ideation and behavior assessment tool (SIBAT): evaluation of intra- and inter-rater reliability, validity and mapping to Columbia classification algorithm of suicide assessment. Psychiatry Res. 2020;294:113495.
Article
PubMed
Google Scholar
Fonseka TM, Bhat V, Kennedy SH. The utility of artificial intelligence in suicide risk prediction and the management of suicidal behaviors. Aust N Z J Psychiatry. 2019;53(10):954–64.
Article
PubMed
Google Scholar
D’Hotman D, Loh E. AI enabled suicide prediction tools: a qualitative narrative review. BMJ Health Care Inform. 2020;27(3):e100175.
Article
PubMed
PubMed Central
Google Scholar